Live feed
·
INSIDERFilingvia Quantisnow
ContraFect Corporation logo

ContraFect (CFRX) executive Cassino received 160,000 Options (Right to Buy)

ByQuantisnow·Wall Street's wire, on your screen.
Stocks in this Quantisnow insight

Insider transactions reported

Cara M Cassino (executive at ContraFect Corporation, CFRX) reported that they received 160,000 Options (Right to Buy) on Feb 15, 2022.

Reporting person
Cassino Cara M

Options and other derivatives

Options and other derivative transactions
DateTypeSecuritySharesPriceValueHeld after
Feb 15, 2022Grant or award (A)Options (Right to Buy)On 160,000 Common Stock1+160,000$3.33$533K160,000 direct

Holdings before and after

  • Options (Right to Buy): 0 to 160,000 direct

Footnotes from the filing

  1. 1. The option vests and becomes exercisable in equal quarterly installments with 6.25% of the total underlying shares vesting at the end of each quarter following the vesting commencement date, subject to continued service with the issuer through each vesting date.

Transaction codes in this filing

Grant or award:
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.

FAQ

What did Cassino report in this CFRX Form 4?

Cara M Cassino (executive at ContraFect Corporation, CFRX) reported that they received 160,000 Options (Right to Buy) on Feb 15, 2022.

What does transaction code A mean on an SEC Form 4?

Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.

Historical context for CFRX

Earlier insider filings at CFRX

Quantisnow market dataNASDAQ
ContraFect Corporation logo
CFRX
ContraFect Corporation
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Listed since
2014
Get push alerts for CFRX

Follow CFRX and get a push notification the moment its next story breaks.

Full CFRX profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CFRX (ContraFect Corporation) and more on Quantisnow.